Introduction {#s1}
============

The CRISPR-Cas system is an adaptive immune system present in many archaeal and bacterial species. It provides immunity against viruses and other mobile genetic elements mediated through sequence homology-directed detection and destruction of foreign nucleic acid species (reviewed in [@bib28]; [@bib3]; [@bib30]). Organisms with an active CRISPR-Cas system encode one or more CRISPR loci in their genomes. These comprise a leader sequence followed by an array of short, direct, often palindromic repeats interspersed by short 'spacer' sequences, together with a variable number of CRISPR associated (*cas*) genes. Spacers are derived from mobile genetic elements and constitute a 'memory' of past infections. The CRISPR locus is transcribed from the leader, generating pre-CRISPR RNA (pre-crRNA) that is subsequently processed into unit length crRNA species and loaded into large ribonucleoprotein complexes. These complexes, known as 'Interference', 'Effector' or 'Surveillance' complexes, utilize crRNA to detect and degrade cognate invading genetic entities, providing immunity against previously encountered viruses and plasmids.

The process of foreign DNA capture and integration into the CRISPR locus is known as 'Acquisition' or 'Adaptation' (reviewed in [@bib10]; [@bib14]). This process underpins the whole CRISPR-Cas system, but is the least well understood aspect. Fundamentally, acquisition can be separated into two steps: the capture of new DNA sequences from mobile genetic elements, followed by the integration of that DNA into the host genome. New spacers are incorporated proximal to the leader sequence and result in the duplication of the first repeat ([@bib12]; [@bib33]). The leader sequence proximal to the repeat is important for integration, but transcription of the locus is not required ([@bib33]). New spacers are frequently incorporated in both possible orientations ([@bib27]). The integration process in *Escherichia coli* results in staggered cleavage of the first CRISPR repeat, where the 3′-end of one strand of the incoming DNA is joined to the end of the CRISPR repeat in a trans-esterification (TES) reaction, with another TES reaction occurring on the other strand ([@bib8]) ([Figure 1](#fig1){ref-type="fig"}, numbered yellow arrows). Intermediates in this reaction have been observed in *E. coli*, and the sequence of the leader-repeat1 junction is important for the activity ([@bib1]). The order of the two integration steps shown in [Figure 1](#fig1){ref-type="fig"} is not yet known, although it has been suggested that the reaction on the minus strand (site 2) occurs first in *E. coli* ([@bib24]). The sequence at site 2 is flanked by the end of the first repeat and the first spacer, and is therefore inherently less well conserved. In *E. coli*, the last nucleotide of the newly copied repeat is derived from the first nucleotide of the incoming spacer, which imposes further sequence requirements on that system ([@bib29]).10.7554/eLife.08716.003Figure 1.CRISPR spacer acquisition and Cas1.(**A**, 1) The 3′-end of an incoming protospacer attacks the chromosomal CRISPR locus at the boundary between the leader sequence and repeat 1. A trans-esterification (TES) reaction (yellow arrow 1) catalyzed by Cas1 joins the protospacer to the 5′ end of repeat 1. For many integrases a (reverse) disintegration reaction can be observed in vitro. (2) Another TES reaction (yellow arrow 2) joins the other strand of the protospacer to the 5′ end of repeat 1 on the bottom (minus) strand, resulting in the formation of a gapped DNA duplex. (3) The gapped duplex is repaired by the host cell DNA replication machinery, resulting in the addition of a new spacer at position 1 and replication of CRISPR repeat 1. (**B**) Sequences flanking the two TES reaction sites at repeat 1 in *Sulfolobus solfataricus* and *Escherichia coli* are shown. The leader is in blue, repeat in black and spacer 1 in teal. The number of central nucleotides of the repeat omitted from the sequence is shown in parentheses. (**C**) Structure of Cas1 from *Pyrococcus horikoshii* (PDB 4WJ0) with subunits coloured blue and cyan, showing the dimeric 'butterfly' conformation with the active site residues highlighted in green.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.003](10.7554/eLife.08716.003)

Although shown in [Figure 1](#fig1){ref-type="fig"} as fully double-stranded, the incoming spacer DNA could have a partially single-stranded character. Recent work by Sorek and colleagues has shown that the *E. coli* RecBCD helicase--nuclease complex, which processes DNA double-strand breaks for recombination and degrades foreign DNA, is implicated in the generation of viral DNA fragments captured by Cas1 and incorporated into the CRISPR locus as new spacers ([@bib18]). This confirms previous observations linking Cas1 with RecBCD ([@bib2]) and raises some intriguing questions as RecBCD generates ssDNA fragments asymmetrically, generating fragments tens to hundreds of nucleotides long from the 3′ terminated strand and much longer fragments from the 5′ terminated strand (reviewed in [@bib9]). The Cas4 enzyme, which is a 5′ to 3′ ssDNA exonuclease ([@bib35]; [@bib17]), may provide ssDNA fragments for Cas1 in systems lacking RecBCD. However, it is difficult to see how two integration reactions could occur without two 3′ hydroxyl termini ([Figure 1](#fig1){ref-type="fig"}) and half-site integration is not observed with a ssDNA substrate ([@bib24]). Potentially, the ssDNA fragments generated by these nucleases may re-anneal and experience further processing to generate partially duplex molecules of defined size prior to integration by Cas1.

Adaptation requires the products of the *cas1* and *cas2* genes in vivo and these are the most universally conserved of all the *cas* genes ([@bib20]). Cas1 is a homodimeric enzyme with a two-domain structure and a canonical metal dependent nuclease active site in the large domain formed by a cluster of highly conserved residues ([@bib32]) ([Figure 1C](#fig1){ref-type="fig"}). *E. coli* Cas1 has nuclease activity in vitro, with activity observed against double- and single-stranded DNA and RNA substrates ([@bib2]). Some specificity was observed for branched DNA substrates, in particular for DNA constructs resembling replication forks ([@bib2]). Initial biochemical analyses of a panel of archaeal Cas2 enzymes revealed an endonucleolytic activity against ssRNA substrates that could be abrogated by mutation of conserved residues ([@bib4]). In contrast, Cas2 from *Bacillus halodurans* has been shown to be specific for cleavage of dsDNA substrates ([@bib21]). Recently however, Doudna and colleagues demonstrated that *E. coli* Cas1 and Cas2 form a stable complex in vitro and that the 'active site' of Cas2 was not required for spacer acquisition, suggesting that Cas2 may not have a catalytic role in spacer acquisition in vivo ([@bib23]). It is probable that Cas2 acts as an adaptor protein, either bringing two Cas1 dimers together or mediating interactions with other components necessary for spacer acquisition. Recently, Nunez et al. demonstrated that *E. coli* Cas1 can integrate a protospacer into a supercoiled plasmid in vitro, in a reaction stimulated by Cas2. Integration events were observed at the boundaries of most CRISPR repeats and in other areas of the DNA close to palindromic regions, implicating a role for palindromic DNA structure in the adaptation process ([@bib24]).

In order to further mechanistic understanding of the spacer acquisition process, we have undertaken a systematic analysis of the underlying biochemistry. We demonstrate that Cas1 catalyses TES of branched DNA substrates efficiently in vitro in a reaction that represents the reverse- or disintegration of an incoming spacer from the CRISPR locus. The disintegration reactions catalysed by diverse integrases have proven a powerful model system for the understanding of the mechanism of integration. For Cas1, the reaction is strongly sequence dependent with the specificity matching the predicted integration site 1 for both *E. coli* and *Sulfolobus solfataricus* Cas1, and does not require Cas2.

Results {#s2}
=======

Cas1 catalyzes a TES reaction on branched DNA substrates {#s2-1}
--------------------------------------------------------

The Cas1 and Cas2 proteins from *S. solfataricus* (CRISPR-Cas subtype IA) and *E. coli* (CRISPR-Cas subtype IE) were expressed in *E. coli* with N-terminal polyhistidine tags and purified to homogeneity by metal affinity and gel filtration chromatography. Previously, it was demonstrated that *E. coli* Cas1 (EcoCas1) cleaved branched DNA substrates preferentially ([@bib2]). We investigated the activity of *S. solfataricus* Cas1 (SsoCas1) against a DNA substrate with a 5′-flap structure ([Figure 2](#fig2){ref-type="fig"}). By labelling the single-stranded 5′-flap of the downstream duplex at the 5′-end with radioactive phosphorus, we observed cleavage of the flap by SsoCas1, releasing an 18 nt product ([Figure 2B](#fig2){ref-type="fig"}). A variant of SsoCas1 where the active site metal ligand glutamic acid 142 was changed to an alanine (E142A) was inactive, implicating the canonical nuclease active site of Cas1 in the reaction. This result appeared consistent with the earlier studies for EcoCas1 ([@bib2]) and suggested that the ssDNA flap was removed at or close to the branch point. The activity was independent of the presence or absence of SsoCas2, suggesting that Cas2 is not involved in this nuclease activity in vitro.10.7554/eLife.08716.004Figure 2.Disintegration of a branched DNA substrate by SsoCas1.Denaturing gel electrophoresis was used to analyse the products generated by SsoCas1 with a branched DNA substrate (Substrate 1). The 5′ flap (18 nt) was released when the phosphodiester backbone was attacked by the 3′-hydroxyl group at the branch point. The reaction required active Cas1 and was independent of Cas2. DNA lengths are shown in blue (nt). The TES site is indicated with a yellow arrow and the labelled strand with a red star. (**A**) Shows reactions with the continuous strand (black) labelled; (**B**) with the flap (grey) strand labelled and (**C**) with the upstream (green) strand labelled, each on the 5′ end. Lanes: 1, control with no added protein; 2, WT Cas1; 3, Cas2; 4, Cas1 + Cas2; 5, Cas1 E142A variant; 6, E142A Cas1 + Cas2. (**D**) The 5′-flap strand was labelled on the 3′ end with a fluorescein moiety, and the flap reduced to 14 nt (Substrate 1-FAM). Cas1 catalyses the TES reaction generating a 53 nt labelled strand. Lane C: control incubation in absence of Cas1. (**E**) TES reactions were carried out with SsoCas1, or the E142A active site mutant, on a fork substrate containing a nicked SacI restriction site spanning the branch point (SacI substrate). A TES product of 53 nucleotides is visible in lane 2 containing Cas1. The right-hand panel shows the effect of adding SacI restriction enzyme after the TES reaction. The TES product is no longer visible, but a shorter product of 25 nucleotides is present indicating regeneration of the SacI recognition sequence by the TES reaction.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.004](10.7554/eLife.08716.004)

We proceeded to label the other strands of the substrate to follow the reaction products in more detail. The continuous (black) strand was not cleaved by SsoCas1 ([Figure 2A](#fig2){ref-type="fig"}). However, when the 23 nt (green) strand of the upstream duplex presenting a 3′-hydroxyl end at the junction point was labelled we observed the formation of a new, larger DNA species ([Figure 2C](#fig2){ref-type="fig"}). This observation was consistent with a joining or TES of the upstream DNA to the downstream DNA strand by Cas1. By switching to a label at the 3′ end of the downstream duplex we confirmed that the reaction catalyzed by Cas1 involved the joining of the upstream and downstream DNA duplexes with concomitant loss of the 5′-flap ([Figure 2D](#fig2){ref-type="fig"}). The lack of evidence for any shorter DNA species in [Figure 2D](#fig2){ref-type="fig"} was consistent with the conclusion that we were observing a TES rather than a nuclease reaction. Again, the TES reaction was unaffected by the presence or absence of Cas2 and was dependent on the wild-type active site of Cas1, as the E142A variant was inactive.

In order to define the product of the TES reaction in more detail, we modified the sequence of the branch point to introduce an interrupted site for the restriction enzyme *SacI* across the junction. A precise TES reaction at the branch point to generate duplex DNA would result in the 'repair' of the restriction site, generating a substrate for *SacI*. SsoCas1 processed this substrate generating the 53 bp TES reaction product. On addition of the *SacI* restriction enzyme, the 53 bp species was converted to a 25 bp product ([Figure 2E](#fig2){ref-type="fig"}). This confirmed that the Cas1-mediated reaction resulted in the formation of a functional *SacI* site in vitro, consistent with a precise TES reaction at the branch point.

It is likely that the TES reaction catalyzed by Cas1 with branched DNA substrates in vitro represents the reverse or disintegration of an integration intermediate, as observed recently for EcoCas1 ([@bib24]). We therefore tested EcoCas1 with the same set of branched substrates, showing that manganese, magnesium and cobalt all supported the same robust disintegration activity in the absence of Cas2, with no nuclease activity observed ([Figure 3A](#fig3){ref-type="fig"}). Given that Eco and SsoCas1 are divergent members of the Cas1 family, this suggests that the disintegration activity is likely to be a general property of Cas1 enzymes. Experiments where the concentration of Cas1 was titrated against a fixed concentration of substrate (50 nM), showed that maximal activity plateaued above 250 nM for EcoCas1 and was maximal from 100 to 500 nM for SsoCas1 ([Figure 3B,C](#fig3){ref-type="fig"}).10.7554/eLife.08716.005Figure 3.TES activity of *E. coli* and *S. solfataricus* Cas1.(**A**) *E. coli* Cas1 also catalyses an efficient metal dependent disintegration reaction. TES reactions were carried out under standard conditions, using Substrate 3 and varying the divalent metal ion as indicated. EcoCas1 showed robust TES activity in the presence of cobalt, magnesium and manganese. Each of the three strands of the substrate was labelled individually as for [Figure 2](#fig2){ref-type="fig"} (5′ label indicated by a star). Lanes were: c, substrate alone; substrate incubated with Cas1 and 5 mM of E, EDTA; Co, cobalt chloride; Ca, calcium chloride; Mg, magnesium chloride; Mn, manganese chloride for 30 min at 37°C. (**B**) Concentration dependence of Cas1 TES activity. Substrate 3 (50 nM) was incubated with the indicated concentration of Sso or EcoCas1 for 30 min under standard assay conditions and the reactants were analysed by denaturing gel electrophoresis and phosphorimaging. SsoCas1 showed maximal activity at 250 nM, representing a fivefold molar excess of enzyme over substrate, with a decline in activity above 500 nM enzyme. EcoCas1 had maximal activity that plateaued above 250 nM enzyme. (**C**) Quantification of the data (raw data provided in [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}). These data are representative of duplicate experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.005](10.7554/eLife.08716.005)10.7554/eLife.08716.006Figure 3---source data 1.Concentration Cas1.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.006](10.7554/eLife.08716.006)

To characterise the specificity of the disintegration reaction in more detail, we examined SsoCas1 activity for a variety of substrates differing in the nature of the 5′-flap or duplex arm released by the reaction ([Figure 4](#fig4){ref-type="fig"}). SsoCas1 was indifferent to the presence of duplex or single-stranded DNA in the 5′-flap, processing a nicked 3-way junction with a similar efficiency to the 5′-flap substrate. The disintegration reaction required the presence of the 3′-hydroxyl moiety at the branch point as a three-way (or Y) junction was not a substrate for Cas1. To confirm this observation we studied a 5′-flap substrate with a phosphate moiety at the 3′ end of the upstream strand in place of a hydroxyl group. As expected, this substrate did not support disintegration activity for either Sso or EcoCas1, with no larger TES product detected (right hand lanes). Tellingly, neither enzyme cleaved the 5′-flap of this substrate to generate shorter products (left hand lanes), confirming that Cas1 catalyses a concerted TES reaction rather than a sequential 'cut and join' activity.10.7554/eLife.08716.007Figure 4.Importance of flap and 3′ terminus structure.The importance of the released 25 nt 5′-flap structure was investigated by varying the length of duplex DNA in that arm from 0 (canonical 5′-flap) to a full 25 bp (nicked 3-way junction) (left hand panel, all based on substrate 19). All supported robust disintegration activity by SsoCas1. An intact Y- junction did not support TES activity. Lanes: C, substrate alone (1, 5, 9, 13, 17); E, SsoCas1 E142A variant 30 min incubation (2, 6, 10, 14, 18); incubation with wild-type SsoCas1 for 10 and 30 min (other lanes). The right hand panel shows the effect of replacing the attacking 3′-hydroxyl moiety at the branch point with a phosphate group (3′ phos substrate) no TES or nuclease activity was observed for either Sso or EcoCas1. C, substrate alone; E, SsoCas1 E142A variant.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.007](10.7554/eLife.08716.007)

Sequence specificity of the disintegration reaction {#s2-2}
---------------------------------------------------

Disintegration reactions are commonly seen for integrases and transposases, and represent a very useful means to study the underlying integration mechanism ([@bib6]; [@bib7]) as the local arrangement of the DNA in the integrase active site is typically the same for the two reactions ([@bib11]). One prediction of this hypothesis is that the disintegration reaction could demonstrate some sequence preference if integration, which must happen at a specific, defined site in the CRISPR locus, is partly driven by the sequence specificity of Cas1. We therefore designed a family of related disintegration substrates by systematically varying the nucleotides flanking the TES site and tested how efficiently Cas1 could disintegrate these substrates. Having demonstrated conclusively that we could follow the progress of the disintegration reaction by monitoring the liberation of a displaced DNA strand from a 5′-flap substrate, we used this assay for all subsequent investigations.

The +1 position {#s2-3}
---------------

We first tested the importance of the nucleotide acting as an acceptor for the attacking 3′-hydroxyl of the incoming DNA strand (the +1 position) by varying the nucleotide at this position in the model substrates ([Figure 5](#fig5){ref-type="fig"}). In vivo, this acceptor nucleotide should represent the position in the CRISPR locus where new spacers are joined to the end of the repeat. The *S. solfataricus* CRISPR repeat has a guanine at one end and a cytosine at the other, each of which are predicted to act as acceptors for a new phosphodiester bond formed with the incoming spacer ([Figure 1B](#fig1){ref-type="fig"}). Consistent with this, we observed the most efficient disintegration activity with SsoCas1 when substrates had a guanine at the +1 position ([Figure 5A](#fig5){ref-type="fig"}). Assays were carried out in triplicate and the reaction products quantified, confirming the qualitative observation of a preference for guanine, followed by cytosine, adenine and thymine, with rates of 0.06, 0.013, 0.0058 and 0.0009 min^−1^, respectively ([Figure 5B](#fig5){ref-type="fig"}).10.7554/eLife.08716.008Figure 5.Sequence specificity of the disintegration reaction at the +1 position.The nucleotide at the acceptor (+1) position was varied systematically to assess the sequence dependence of the disintegration reaction carried out by Cas1 from *S. solfataricus* (**A**, **B**) and *E. coli* (**C**, **D**) (Substrates 3, 6, 7, 8). In the gels on the left (**A**, **C**) each substrate was incubated with Cas1 for 1, 2, 3, 5, 10, 15, 20 and 30 min in reaction buffer prior to electrophoresis to separate the cleaved 5′-flap from the intact substrate. C--control with no Cas1 added. The plots on the right (**B**, **D**) show quantification of these assays. Data points represent the means of triplicate experiments with standard errors shown (raw data provided in [Figure 5---source data 1](#SD2-data){ref-type="supplementary-material"} and [Figure 5---​source data 2](#SD3-data){ref-type="supplementary-material"}). The data were fitted to an exponential equation, as described in the 'Materials and methods', and for EcoCas1 a variable floating end point was included to allow fitting as the reaction did not go to completion. The effect of Cas2 (150 nM) on EcoCas1 (150 nM) sequence specificity for substrates (50 nM) varying at position +1 (substrates 3, 6, 7, 8) was also tested (**E**). The second panel from the right is a composite image from two phosphorimages of the same time course as indicated by a black line.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.008](10.7554/eLife.08716.008)10.7554/eLife.08716.009Figure 5---source data 1.Nucleotide at +1 position.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.009](10.7554/eLife.08716.009)10.7554/eLife.08716.010Figure 5---source data 2.Nucleotide at +1 position.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.010](10.7554/eLife.08716.010)

For *E. coli*, the first nucleotide of the repeat is a guanine. Although the corresponding position at the other end of the repeat on the minus strand is a cytosine, it has been demonstrated that the new spacer joins at the penultimate residue, which is also a guanine ([@bib29]). EcoCas1 displayed a striking preference for a guanine at the +1 position for the disintegration reaction, with all three alternative nucleotides strongly disfavoured at this position ([Figure 5C](#fig5){ref-type="fig"}), in good agreement with the prediction based on the repeat sequence. For EcoCas1 the reaction did not go to completion and accordingly we fitted the data with a variable end-point as described in the 'Materials and methods' ([Figure 5D](#fig5){ref-type="fig"}). Although the reaction rates could not be determined accurately, guanine at position +1 supported rates at least 10-fold higher than any other nucleotide. We also tested the effect of inclusion of Cas2 on the sequence specificity of EcoCas1, and observed that Cas2 had no effect, with strong preference for a guanine at +1 still observed ([Figure 5E](#fig5){ref-type="fig"}).

The −1 position {#s2-4}
---------------

We proceeded to investigate the sequence dependence of the nucleotide at the 3′-end of the attacking DNA strand (the −1 position) in the disintegration reactions. For the first integration site, this should correspond to the last nucleotide of the leader sequence, which is an adenine in both *S. solfataricus* and *E. coli.* Although both Cas1 enzymes catalyzed the disintegration of substrates with an adenine at this position, clear sequence preference was not apparent ([Figure 6](#fig6){ref-type="fig"}). For *S. solfataricus,* the −1′ position on the minus strand is variable in sequence. However, in *E. coli*, site 2 occurs at the penultimate nucleotide of the repeat and therefore has a cytosine at the −1′ position ([@bib29]). In this situation, the incoming 3′ terminal nucleotide of the spacer has to be a cytosine in order to complete the original repeat sequence. To mimic the TES substrate at this site more closely, we tested substrates where the first nucleotide of the 5′ flap, equivalent to the incoming nucleotide in the forward reaction, was a cytosine, but a cytosine at position −1 was still not favoured by EcoCas1 ([Figure 6C](#fig6){ref-type="fig"}). This may suggest that the disintegration reaction is not a good model for integration at site 2, which is further discussed later.10.7554/eLife.08716.011Figure 6.Sequence specificity of the disintegration reaction at the −1 position.The nucleotides participating in the disintegration reaction were varied systematically at the −1 position (substrates 3, 9, 10, 11). For SsoCas1 (**A**) there was some preference for adenine at this position, consistent with integration site 1. For EcoCas1 (**B**, **C**), a cytosine at position −1 was disfavoured over all other possibilities, even when the residue equivalent to the 'incoming' nucleotide was also a cytosine (substrates 15, 16, 17, 18). Each substrate was incubated with Cas1 for 5, 10 and 30 min in reaction buffer prior to electrophoresis. C--control with no Cas1 added.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.011](10.7554/eLife.08716.011)

The −2 position {#s2-5}
---------------

The nucleotide at the −2 position, which is part of the conserved leader sequence for integration site 1, is also a potential determinant of integration specificity. Accordingly, we varied this residue systematically and investigated the efficiency of the disintegration reaction for both Cas1 enzymes ([Figure 7](#fig7){ref-type="fig"}). In *S. solfataricus*, the −2 position in the leader is a cytosine, which supported the strongest disintegration activity ([Figure 7A](#fig7){ref-type="fig"}). In *E. coli*, the −2 position in the leader is a guanine. A clear preference for guanine over all other nucleotides was observed for EcoCas1 ([Figure 7B](#fig7){ref-type="fig"}), confirmed by a more detailed kinetic analysis ([Figure 7C](#fig7){ref-type="fig"}) which was fitted as for [Figure 5D](#fig5){ref-type="fig"}. These data are consistent with a role for sequence discrimination at the −2 position by both enzymes, which is relevant for integration site 1 but not site 2, where this position varies depending on the sequence of the last spacer inserted.10.7554/eLife.08716.012Figure 7.Sequence specificity of the disintegration reaction at the −2 position.The nucleotides participating in the disintegration reaction were varied systematically at the −2 position, which is a cytosine (Sso) or guanine (Eco) at integration site 1, and variable at integration site 2 (substrates 10, 12, 13, 14). (**A**) SsoCas1; (**B**) EcoCas1. Each substrate was incubated with Cas1 for 5, 10 and 30 min in reaction buffer prior to electrophoresis. C--control with no Cas1 added. (**C**) For EcoCas1, the clear preference for guanine at position −2 was confirmed by more detailed kinetic analysis (raw data provided in [Figure 7---source data 1](#SD4-data){ref-type="supplementary-material"}) as described for [Figure 5](#fig5){ref-type="fig"}.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.012](10.7554/eLife.08716.012)10.7554/eLife.08716.013Figure 7---source data 1.Nucleotide at −2 position.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.013](10.7554/eLife.08716.013)

The incoming nucleotide {#s2-6}
-----------------------

We next checked for specificity at the 3′ end of the 5′ flap in the disintegration product, which corresponds to the 3′ end of the incoming spacer during integration. No sequence preference was detected for SsoCas1 (data not shown), which is consistent with the essentially random nature of the incoming DNA. During adaptation in *E. coli*, the incoming nucleotide at integration site 1 is expected to be random, but at site two is always a cytosine, where it completes the repeat sequence ([@bib29]). For EcoCas1, an adenine or cytosine was strongly favoured over guanine and particularly thymine ([Figure 8](#fig8){ref-type="fig"}), suggesting discrimination by EcoCas1 at this position.10.7554/eLife.08716.014Figure 8.Sequence specificity of the EcoCas1 disintegration reaction for the incoming nucleotide.The nucleotide corresponding to the incoming 3′ end of the new spacer, which is the nucleotide at the 3′ end of the 5′-flap in the disintegration substrate, was varied systematically to determine its effect on the disintegration reaction catalysed by EcoCas1 (substrates 2, 3, 4, 5). C--control with no Cas1 added. Time points were 5, 10 and 30 min.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.014](10.7554/eLife.08716.014)

Disintegration of authentic *E. coli* integration intermediates {#s2-7}
---------------------------------------------------------------

The substrates examined so far in this study do not correspond to the actual sequences encountered by EcoCas1 during integration. Accordingly, we constructed a pair of substrates that correspond to the products of integration when spacer 3 in the *E. coli* CRISPR array is integrated at site 1 (top strand) or site 2 (bottom strand) ([Figure 9](#fig9){ref-type="fig"}). These were constructed from oligonucleotides as before to generate disintegration substrates with a 5′ flap. Disintegration was analysed by denaturing gel electrophoresis, phosphorimaging and quantification of triplicate experiments. EcoCas1 disintegrated the site 1 substrate quickly, with the reaction reaching approximately 75% conversion in 3 min, which compares favorably with the best model sequence studied. Site 2 was also a good disintegration substrate, though it was converted significantly more slowly than site 1, perhaps due to the presence of a disfavored cytosine at position −1.10.7554/eLife.08716.015Figure 9.Disintegration of authentic *E. coli* integration intermediates.Disintegration substrates corresponding to the expected site 1 and site 2 integration products arising from the integration of spacer 3 into the CRISPR array were constructed and tested (spacer 3-1 and spacer 3-2 substrates). EcoCas1 processed both, with the rate of reaction significantly higher for the substrate corresponding to site 1 (the top strand) at the leader-repeat junction. Data points represent the means of triplicate experiments with standard errors shown (raw data provided in [Figure 9---source data 1](#SD5-data){ref-type="supplementary-material"}).**DOI:** [http://dx.doi.org/10.7554/eLife.08716.015](10.7554/eLife.08716.015)10.7554/eLife.08716.016Figure 9---source data 1.*E. coli* Site 1 vs Site 2 time course.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.016](10.7554/eLife.08716.016)

Discussion {#s3}
==========

Studies of the CRISPR spacer acquisition process in vivo have yielded many key insights, but they are complicated by the fact that it is very difficult to separate the two distinct steps of spacer capture and spacer integration. Consequently we still do not have a clear understanding of the roles of Cas1, Cas2 and host proteins in the acquisition mechanism. In this study we investigated the integration reaction by focusing on the biochemistry of the Cas1 protein from *S. solfataricus* and *E. coli*. Efficient TES of branched DNA substrates with a 5′-flap or duplex arm is clearly possible for both *S. solfataricus* and *E. coli* Cas1 in vitro. This is a very precise reaction requiring attack by a 3′-hydroxyl at the branch point, generating a perfect DNA duplex. The reaction almost certainly represents the disintegration reaction that is the reverse of the spacer integration step, as observed for many integrases and transposases where it represents a very useful means to study the underlying integration mechanism ([@bib11]). Evidence for a disintegration activity was recently described by Doudna and colleagues for EcoCas1, but the activity observed was relatively weak, most likely because the branched substrate studied had a non-optimal DNA sequence around the branch point ([@bib24]).

For the CRISPR adaptation process in vivo, integration occurs at the junction between the first repeat and the leader sequence, which immediately suggests a role for sequence specificity in the reaction. It has also been suggested that CRISPR repeat sequences, which are often palindromic, form four-way DNA junctions in supercoiled DNA, acting as a recognition signal for Cas1, a possibility that is supported by the observation that EcoCas1 can cut four-way DNA junctions in vitro ([@bib2]), and the finding that spacer integration in a plasmid lacking a CRISPR locus occurs preferentially next to a palindromic site ([@bib24]). However, a palindrome alone is not sufficient to support spacer insertion in *E. coli* in vivo ([@bib1]), and this also holds for the type II CRISPR system of *Streptococcus thermophilus* ([@bib31]), suggesting that local sequence helps determine the integration site. Furthermore, some CRISPR repeat families, including many in archaea, have little or no palindromic nature and thus cannot form stable hairpin structures ([@bib16]). Cas1 therefore might be expected to act as a sequence specific integrase, although local DNA structure could also play a part.

In support of this hypothesis, both *S. solfataricus* and *E. coli* Cas1 catalyse a disintegration reaction with distinct, sequence specific properties. In particular, there is a clear preference for a guanine at position +1, corresponding to the first nucleotide of the repeat, suggesting that this residue is recognised specifically in the active site of Cas1. The specificity is particularly strong for EcoCas1, consistent with the presence of a guanine in the repeat sequence at the +1 site in both plus and minus strands. Preference for a guanine at the +1 nucleotide for EcoCas1 catalysed integration events has also been observed ([@bib24]). For SsoCas1, a guanine at this position was preferred over a cytosine, which is the nucleotide present at the +1′ position on the minus strand, by a factor of five. Although the −1 position might also be expected to play a role in the selection of integration sites, deep sequencing data for integration catalysed by EcoCas1 revealed no sequence preference at this position ([@bib24]). In agreement with this finding, we observed little evidence for sequence discrimination at the −1 position for the disintegration reactions catalysed by either enzyme, with the exception that EcoCas1 disfavours cytosine at this position ([Figure 6B](#fig6){ref-type="fig"}). A cytosine at position −1 is the expected residue on the minus strand, suggesting that the disintegration reaction may better reflect the reversal of integration at site 1 in the leader-repeat junction. Deep sequencing data for integration reactions catalysed by EcoCas1 in vitro did reveal a marked preference for a guanine at position −2 in the integration site ([@bib24]). This corresponds well with the −2 position in the plus strand, which is part of the leader sequence and is a guanine in *E. coli,* but cannot hold for the minus strand where the −2′ position is inherently variable in nature. Disintegration of substrates mimicking the integration intermediates relevant for the integration of spacer 3 into the *E. coli* CRISPR array reinforce these conclusions, with site 1 on the plus strand processed significantly more quickly than site 2 on the bottom strand ([Figure 9](#fig9){ref-type="fig"}). Taken together, both the disintegration specificity and the deep sequencing data for integration support the hypothesis that integration is targeted to the leader-repeat 1 junction on the plus strand at least in part by the inherent sequence specificity of Cas1, which presumably involves specific recognition of these bases within the active site of the enzyme ([Figure 10](#fig10){ref-type="fig"}).10.7554/eLife.08716.017Figure 10.Reaction scheme for spacer integration and disintegration by *E. coli* Cas1.The Cas 1-2 complex integrates new spacers via two joining reactions (1 and 2) at either end of the first CRISPR repeat, which differ in their sequence context. Disintegration activity by *E. coli* Cas1 shows clear preference for the sequence at site 1, with the guanines at position +1 and −2 particularly important. At site 2, the sequence context is not optimal for disintegration in vitro, leading to slower reaction rates. In the active site of Cas1, these nucleobases likely make specific interactions with catalytic residues, and the DNA duplex structure may be distorted.**DOI:** [http://dx.doi.org/10.7554/eLife.08716.017](10.7554/eLife.08716.017)

For *E. coli* integration reactions in vitro, a marked preference for cytosine over thymine at the 3′ end of the protospacer was observed ([@bib24]). Furthermore, protospacers with a cytosine at the 3′ end were preferentially incorporated into the minus strand at the junction between repeat 1 and spacer 1. These data are consistent with the requirement for protospacers to supply the final cytosine of the repeat on the minus strand during integration ([@bib29]). The deep sequencing data also revealed a marked preference for adenine over thymine at the 3′ end of the protospacer ([@bib24]). For disintegration by EcoCas1, we observed a clear preference for adenine or cytosine at the equivalent position, whilst thymine did not support the disintegration reaction ([Figure 8](#fig8){ref-type="fig"}). Thus EcoCas1 appears to recognise the nucleotide at the 3′ end of the incoming DNA, although no such discrimination was observed for SsoCas1. A dinucleotide sequence 'AA' motif over-represented at the 3′ end of protospacers incorporated in *E. coli* strain BL21 has been described previously ([@bib34]).

Although the CRISPR spacer integration system has been compared to the integration and transposition reactions carried out by mobile genetic elements, there is one key difference in the two processes---the length of DNA integrated. The persistence length of DNA, the distance over which it behaves as a fairly rigid rod, is estimated as 35--50 nm (100--150 bp) under conditions found in cells ([@bib13]; [@bib5]). This means that the two ends of a viral genome of several kilobases can be looped around and brought close together relatively easily, but a new spacer of 30--40 base pairs of dsDNA cannot be manipulated in the same way. Considering the scheme in [Figure 1](#fig1){ref-type="fig"}, the molecular origami required to achieve the second TES reaction looks challenging. Several related enzymes, including Mu transposase ([@bib26]), V(D)J recombinase ([@bib25]) and HIV integrase ([@bib11]) are known to disrupt base pairing of DNA substrates and make sequence-specific contacts during the integration reaction. It is likely that Cas1 also manipulates the local DNA duplex structure, which may help in positioning the DNA strands correctly for the TES reaction. The observation that the incoming DNA (the 5′-flap in the disintegration reaction) can be single stranded, partially or fully duplex in nature suggests that there is some flexibility in the recognition of the incoming spacer. This is also consistent with the recent observation of a link between RecBCD, which generates ssDNA products, and Cas1 in *E. coli* ([@bib18]). There is no formal requirement that the protospacer should be fully duplex in nature, although current understanding of the integration reaction requires that new spacers have two intact 3′-ends for the two integration reactions so must be at least partially duplex in nature. Many integrases process the ends of the integrated DNA using a nuclease activity, which occurs at the same active site as the integrase activity ([@bib11]). There is no reason to expect that Cas1 will differ in that regard, and indeed the reaction products of the RecBCD nuclease are on average much longer than the DNA molecules integrated by Cas1, suggesting the requirement for further processing.

In conclusion, we have shown that Cas1 from both *S. solfataricus* and *E. coli* have robust TES activities in vitro which reflect the reversal, or disintegration, of the integration reaction. Disintegration is strongly sequence specific, and the specificity fits with the expected sequence for the plus strand at the leader-repeat junction ([Figure 9](#fig9){ref-type="fig"}). This site is the logical place for the initiation of integration, as it has a unique, defined sequence, in contrast to the repetitive and more variable sequence found at the second integration site on the minus strand. Doudna and colleagues recently proposed a model based on an initial attack at site 2 on the minus strand ([@bib24]). However, this preference was only significant for spacers with a cytosine at the 3′ terminus, and does not explain the marked preference observed by the authors for a guanine at position +2, which is a feature of the positive strand. Future studies of both the forward and reverse integration reactions catalyzed by Cas1 will help to address these issues and delineate the mechanism of spacer integration in the CRISPR system.

Materials and methods {#s4}
=====================

Cloning, gene expression and protein purification {#s4-1}
-------------------------------------------------

The *sso1450* (*cas1*) gene and *sso1450a* (*cas2*) genes were amplified from *S. solfataricus* P2 genomic DNA by PCR using primer pairs (5′-ATATAACCATGGCAAGCGTGAGGACTT; 5′-TATTGGATCCTCACATCACCAACTTGAAACCC) and (5′-GCGCCATGGTTACACTAACCATTCCTCTAATC; 5′-GGCCGGATCCTTGAAATTATTGGTAGTATATGAC), respectively. The amplified genes were cloned into the pEHisTEV vector ([@bib19]) downstream of a cleavable His~6~-tag using *Nco*I and *Bam*HI restriction sites. Site-directed mutagenesis was carried out on the vector containing *sso1450* to mutate active site residue glutamic acid 142 to an alanine using the oligonucleotide sequence 5′-GTTGGATAAGGATGCACCGGCTGCTGCTAG. Standard site-directed mutagenesis protocols (QuikChange, Stratagene, La Jolla, CA, United States) were followed. Mutations were confirmed by sequencing (GATC Biotech, Constance, Germany). The constructs were expressed in C43 (DE3) *E. coli* cells grown in LB (Luria-Bertani) medium supplemented with 35 µg/ml kanamycin to an OD~600~ of 0.6--0.8 at 37°C. Expression was then induced by the addition of 0.4 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and overnight incubation with shaking at 25°C. Cells were harvested (8000×*g*, 20 min) and resuspended in lysis buffer (4.5 mM NaH~2~PO~4~, 15 mM Na~2~HPO~4~ \[pH 7.5\], 500 mM NaCl, 30 mM imidazole, 1% Triton-X and protease inhibitors \[Roche Applied Science, Basel, Switzerland\]). Cells were lysed by sonication, the lysate cleared by ultracentrifugation (90,000×*g*, 35 min) and the supernatant filtered though a 0.22 µm syringe filter and loaded on to a HP HisTrap 5 ml column (GE Healthcare, Little Chalfont, United Kingdom) equilibrated in buffer A (4.5 mM NaH~2~PO~4~, 15 mM Na~2~HPO~4~ \[pH 7.5\], 500 mM NaCl, 30 mM imidazole). The His-tagged protein of interest was eluted with a linear gradient from 30 to 500 mM imidazole. Fractions containing Cas1 (or Cas2) were concentrated and buffer exchanged into buffer A, using centrifugal concentrators (30 kDa cutoff, Vivaspin, Sartorius Stedim Biotech GmbH, Goettingen, Germany). His-tags were cleaved by the addition of TEV protease (1:10 ratio of TEV:protein) and overnight incubation at room temperature. The cleaved protein was passed through a HisTrap column in buffer A, and the cleaved protein collected in the flow through. The final purification step was gel filtration on a 26/60 Superdex 200 prep grade column (GE Healthcare) in buffer C (20 mM Tris-HCL (pH 7.5), 500 mM NaCl, 0.5 mM DTT, 1 mM EDTA, 10% glycerol). Purified and concentrated protein samples were flash frozen and stored at −80°C.

Genes encoding *E. coli* K-12 MG1655 Cas1 (*ygbT*) and Cas2 (*ygbF*) were amplified by PCR from genomic DNA using the PCR primer pairs (5′-GGAATTCCATATGACCTGGCTTCCCCTTAATC; 5′-GGAATTCTCAGCTACTCCGATGGCCTGC) and (5′-GGAATTCCATATGAGTATGTTGGTCGTGGTCAC; 5′-GGAATTCTCAAACAGGTAAAAAAGACAC), respectively. Each PCR product was subcloned into protein expression plasmid pET14b using restriction enzyme *Nde*I and *Eco*RI. EcoCas1 and Cas2 proteins were over-produced individually in strain BL21 AI (Life Technologies, Carlsbad, CA, United States), each with N-terminal (His)~6~ tags. Cells were grown at 37°C to OD~600~ 0.5--0.6 in LB broth containing ampicillin (50 µg/ml) and induced using IPTG (1 mM) and arabinose (0.2% wt/vol), with growth continued for 3 hr after induction. Cas1 or Cas2 expressing cells were harvested for re-suspension in buffer H (20 mM Tris.HCl pH7.5, 500 mM NaCl, 5 mM imidazole, 10% glycerol) and flash frozen in liquid nitrogen for storage at −80°C until required. The first purification step was identical for both Cas1 and Cas2: sonicated biomass was clarified by centrifugation (90,000×*g*, 25 min) and soluble extract was passed into a 5 ml Hi-Trap Nickel chelating column (GE Healthcare) equilibrated with buffer H. Cas1 or Cas2 eluted at 70--100 mM imidazole in a linear imidazole gradient. Sodium chloride was reduced to 50 mM by dialysis against buffer S (20 mM Tris.HCl pH7.5, 50 mM NaCl, 1 mM DTT, 10% glycerol). Cas1 was loaded onto a 5 ml Hi-Trap heparin column and eluted in a gradient of NaCl at 200--300 mM in buffer S. Pooled Cas1 fractions were loaded directly onto a S300 size exclusion column equilibrated in buffer S with 250 mM NaCl. Cas1 fractions were pooled for storage at −80°C in buffer S containing 250 mM NaCl and 40% glycerol. Desalted Cas2 eluted from Ni-NTA was dialyzed into buffer S containing 1.5 M NaCl and applied to a 5 ml Hi-Trap butyl-Sepharose column (GE Healthcare), eluting in the flow through. Cas2 fractions were pooled and loaded directly onto a S300 size exclusion column equilibrated in buffer S with 250 mM NaCl. Following isocratic elution, Cas2 fractions were pooled and stored as for Cas1.

Sequence and preparation of DNA substrates {#s4-2}
------------------------------------------

Substrates were purchased from Integrated DNA Technologies (Coralville, IA, United States) either unlabeled or with a 3′-fluorescein label ([Table 1](#tbl1){ref-type="table"}). Oligonucleotides were 5′-^32^P-radiolabelled and gel purified as described previously ([@bib15]). Labelled oligonucleotides were annealed with complementary strands by heating with an excess of unlabelled strands at 95°C for 5 min and then slow cooling to room temperature overnight in a heating block. The assembled substrates ([Table 2](#tbl2){ref-type="table"}) were purified by native polyacrylamide (12%) gel electrophoresis with 1× Tris-borate-EDTA (TBE) buffer, followed by band excision, gel extraction and ethanol precipitation before being resuspended in nuclease free water, as described previously ([@bib15]). The final substrate concentration was measured using the extinction coefficient and absorbance at 260 nm in a UV-Vis spectrophotometer (Varian Cary, Agilent, Santa Clara, CA, United States) and DNA diluted to ∼50 nM or ∼200 nM final concentration for use in assays.10.7554/eLife.08716.018Table 1.Sequence of oligonucleotides used for substrate construction**DOI:** [http://dx.doi.org/10.7554/eLife.08716.018](10.7554/eLife.08716.018)StrandSequence 5′→3′Length1aTAGTAAGAGATTAATAAACCCTCAGATAATCTCTTATAGAATTGAAAGTTCGG531bTTTTTTTTTTTTTTTTTTATTATCTGAGGGTTTATTAATCTCTTACTA481cCCGAACTTTCAATTCTATAAGAG232aTAGTAAGAGATTAATAAACCCTCAGATAACCTCTTATAGAATTGAAAGTTCGG532bTTTTTTTTTTTTTTTTTTGTTATCTGAGGGTTTATTAATCTCTTACTA483bTTTTTTTTTTTTTTTTTAGTTATCTGAGGGTTTATTAATCTCTTACTA484bTTTTTTTTTTTTTTTTTCGTTATCTGAGGGTTTATTAATCTCTTACTA485bTTTTTTTTTTTTTTTTTGGTTATCTGAGGGTTTATTAATCTCTTACTA486aTAGTAAGAGATTAATAAACCCTCAGATAAGCTCTTATAGAATTGAAAGTTCGG536bTTTTTTTTTTTTTTTTTACTTATCTGAGGGTTTATTAATCTCTTACTA487aTAGTAAGAGATTAATAAACCCTCAGATAAACTCTTATAGAATTGAAAGTTCGG537bTTTTTTTTTTTTTTTTTATTTATCTGAGGGTTTATTAATCTCTTACTA488bTTTTTTTTTTTTTTTTTAATTATCTGAGGGTTTATTAATCTCTTACTA489aTAGTAAGAGATTAATAAACCCTCAGATAACATCTTATAGAATTGAAAGTTCGG539cCCGAACTTTCAATTCTATAAGAT2310aTAGTAAGAGATTAATAAACCCTCAGATAACTTCTTATAGAATTGAAAGTTCGG5310cCCGAACTTTCAATTCTATAAGAA2311aTAGTAAGAGATTAATAAACCCTCAGATAACGTCTTATAGAATTGAAAGTTCGG5311cCCGAACTTTCAATTCTATAAGAC2312aTAGTAAGAGATTAATAAACCCTCAGATAACTCCTTATAGAATTGAAAGTTCGG5312cCCGAACTTTCAATTCTATAAGGA2313aTAGTAAGAGATTAATAAACCCTCAGATAACTGCTTATAGAATTGAAAGTTCGG5313cCCGAACTTTCAATTCTATAAGCA2314aTAGTAAGAGATTAATAAACCCTCAGATAACTACTTATAGAATTGAAAGTTCGG5314cCCGAACTTTCAATTCTATAAGTA23SacI-aTAGTAAGAGATTAATAAACCCTCAGATGAGCTCTTATAGAATTGAAAGTTCGG53SacI-bTTTTTTTTTTTTTTCTCATCTGAGGGTTTATTAATCTCTTACTA441b-3′-FAMTTTTTTTTTTTTTTATTATCTGAGGGTTTATTAATCTCTTACTA-FAM4819aCCTCGAGGGATCCGTCCTAGCAAGCCGCTGCTACCGGAAGCTTCTGGACC5019bGCTCGAGTCTAGACTGCAGTTGAGAGCTTGCTAGGACGGATCCCTCGAGG5019cGGTCCAGAAGCTTCCGGTAGCAGCG2520d-10AGTCTAGACTCGAGC1520d-5ACTGCAGTCTAGACTCGAGC2020dTCTCAACTGCAGTCTAGACTCGAGC2525c-dGGTCCAGAAGCTTCCGGTAGCAGCGTCTCAACTGCAGTCTAGACTCGAGC501c-3′PCCGAACTTTCAATTCTATAAGAG-phos25Sp3-1aCTGGCGCGGGGAACTCTCTAAAAGTATACATTTGTTCTT39Sp3-1bTGTAATTGATAATGTTGAGAGTTCCCCGCGCCAG34Sp3-1cAAGAACAAATGTATACTTTTAGA23Sp3-2aCCAGCGGGGATAAACCGTTTGGATCGGGTCTGGAATTTC39Sp3-2bTGTTCCGACAGGGAGCCCGGTTTATCCCCGCTGG34Sp3-2cGAAATTCCAGACCCGATCCAAAC2310.7554/eLife.08716.019Table 2.DNA constructs used in this study**DOI:** [http://dx.doi.org/10.7554/eLife.08716.019](10.7554/eLife.08716.019)SubstrateOligonucleotide componentsJunction sequence−2−11ICSubstrate 11a, 1b, 1cAGATSubstrate 1-FAM1a, 1b-3′-FAM, 1cAGATSacI substrateSacI-a, SacI-b, 1cAGCTSubstrate 22a, 2b, 1cAGGTSubstrate 32a, 3b, 1cAGGA3′-phos substrate2a, 3b, 1c-3′PAGGASubstrate 42a, 4b, 1cAGGCSubstrate 52a, 5b, 1cAGGGSubstrate 66a, 6b, 1cAGCASubstrate 77a, 7b, 1cAGTASubstrate 81a, 8b, 1cAGAASubstrate 99a, 3b, 9cATGASubstrate 1010a, 3b, 10cAAGASubstrate 1111a, 3b, 11cACGASubstrate 1212a, 3b, 12cGAGASubstrate 1313a, 3b, 13cCAGASubstrate 1414a, 3b, 14cTAGASubstrate 152a, 4b, 1cAGGCSubstrate 1611a, 4b, 11cACGCSubstrate 1710a, 4b, 10cAAGCSubstrate 189a, 4b, 9cATGCSubstrate 1919a, 19b, 19cCGGAGap1019a, 19b, 19c, 20d-10CGGAGap519a, 19b, 19c, 20d-5CGGANick19a, 19b, 19c, 20dCGGAY-junction19a, 19b, 20c-dCGGASpacer 3-1 substrateSp3-1a, Sp3-1b, Sp3-1cGAGASpacer 3-2 substrateSp3-2a, Sp3-2b, Sp3-2cACGC[^1]

Disintegration reactions {#s4-3}
------------------------

Reactions were typically carried out under single turnover conditions. Titration of SsoCas1 ([Figure 3B,C](#fig3){ref-type="fig"}) showed evidence for inhibition at enzyme:substrate ratios above 10:1. For standard assays, 2 μM Cas1 protein was mixed with 200 nM substrate in cleavage buffer (20 mM Tris \[pH 7.5\], 10 mM NaCl, 1 mM DTT and 5 mM MnCl~2~) and incubated at 55°C (for SsoCas1) or 37°C (for EcoCas1). For reactions with Cas1 and Cas2, the proteins were mixed in equimolar concentration and incubated together at either 37 or 55°C for 30 min before being added to the reaction. At indicated times, reactions were quenched by the addition of EDTA to 20 mM final concentration and 1 μl 20 mg/ml Proteinase K (Promega, Madison, WI, United States) and incubation at 37°C for 30 min. The DNA was then separated from the reaction by phenol chloroform extraction. 60 μl neutral phenol:chloroform:isoamyl alcohol (Sigma--Aldrich, St. Louis, MO, United States) was added and the reaction vortexed for 30 s. The sample was then centrifuged (15,000×*g*, 1 min) and the upper aqueous phase, containing the DNA, collected. Formamide loading dye (100% formamide with 0.25% bromophenol blue, 0.25% xylene cyanol) was added (5 µl) and the sample heated at 95°C for 2 min before being chilled on ice. Reaction products were resolved on a pre-run 20% denaturing (7 M urea) polyacrylamide gel containing 1× TBE in 1× TBE buffer. Gels were run at 80 W, 45°C for 90 min before overnight exposure to a phosphorimaging plate and imaging with a FLA-5000 Imaging System (Fujifilm Life Science, Düsseldorf, Germany).

*Sac*I site repair {#s4-4}
------------------

Assays with the *Sac*I junction substrate were carried out under standard conditions with SsoCas1 for 30 min. FastDigest *Sac*I enzyme (1 μl) and 1 μl FastDigest Buffer (Thermo Scientific, Waltham, MA, United States) were then added and the reaction incubated at 37°C for 30 min. Product extraction, separation and visualization was then carried out as described above.

Disintegration reaction time courses {#s4-5}
------------------------------------

For the time course assays, the concentration of DNA substrates was 50 nM and the concentration of Cas1 protein 50 nM for SsoCas1 or 500 nM for EcoCas1. Reactions were performed as described above with the omission of the Proteinase K step. Following phosphorimaging, substrates and products were quantified using Image Gauge software (Fujifilm) and the reaction course was plotted using Kaleidagraph (Synergy Software, Reading, PA, United States). Experiments were carried out in triplicate and the mean and standard error calculated for each point. For SsoCas1, the data were fitted using a single exponential ([@bib22]). For EcoCas1 the reactions did not go to completion and were therefore fitted with a floating end-point, as described previously ([@bib22]).
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Thank you for submitting your work entitled "Intrinsic sequence specificity of the Cas1 integrase directs new spacer acquisition" for peer review at *eLife*. Your submission has been favorably evaluated by Jim Kadonaga (Senior Editor), Timothy Nilsen (Reviewing Editor), and three reviewers, one of whom, Erik Sontheimer, has agreed to share his identity.

We have received comments on your manuscript from three experts in the CRISPR field. After discussion among them, it was agreed that you describe work that significantly advances this area. Please address the rather minor comments of Reviewers 1 and 2 and perform the experiments requested by Reviewer 3.

Reviewer \#1:

Rollie et al. present a series of studies on Cas1 (and, to a lesser extent, Cas2) from both *E. coli* and *S. solfataricus*, and on their activities in vitro that relate to their cellular roles in CRISPR spacer acquisition. The authors define an activity that is an apparent reversal (disintegration) of the natural integration pathway, with a 5\'-flap substrate undergoing a transesterification reaction that releases that single-stranded 5\'-flap in concert with the joining of the two flanking base-paired segments. This reaction has previously been used to study the activities of other integrases and recombinases, and also of *E. coli* Cas1/Cas2 in the work of Nunez et al. (Nature, 2015). The appearance of the latter study partly stole a march on the current work, with the primary contributions of this manuscript (i.e. above and beyond the results presented by Nunez et al.) being the inclusion of a separate, distinct Cas1 (SsoCas1) and the more detailed analysis of the sequence preferences of the reactions catalyzed by both Eco and SsoCas1. These contributions are significant, in part because the leader and repeat DNA sequences (where the reactions occur) differ between the relevant strains of *E. coli* and *S. solfataricus*, allowing comparative tests of substrate specificity, and of the roles of Cas1 in establishing that specificity. The authors do in fact establish such differences, and overall the reaction data that is presented is compelling.

A critical question is the degree to which the requirements for disintegration reflect those of the presumptive integration. As an example, the initial protospacer attack (forward) reaction described by Nunez et al. requires a double-stranded protospacer, whereas the disintegration liberates single-stranded (as well as double-stranded) flaps; similarly, the inclusion of Cas2 is far more important for integration than for disintegration. Overall, the history of integrase/transposase research suggests that the reverse reaction can be a useful and convenient proxy for the forward reaction, but this nonetheless calls for some caution in interpretation.

One other potential concern is that the authors used enzyme concentrations that were rather high -- 2 micromolar, according to the Materials and methods section. This is more than twenty-five-fold higher than those used by Nunez et al. Is there a reason for this? The higher concentrations could drive enzyme/substrate interactions that might not occur at concentrations that are probably closer to physiological, and could therefore obviously bear on questions of specificity. This concern is particularly meaningful in light of [Figure 3B](#fig3){ref-type="fig"}, which shows good activity in the low- to mid-nanomolar range. In fact, in light of the SsoCas1 data in [Figure 3B](#fig3){ref-type="fig"}, 2-micromolar reactions should not work at all for that protein. Can the authors explain this discrepancy?

Perhaps the most meaningful question is about the degree to which the results described in this manuscript move the field forward, relative to expectations for this journal. My initial reaction is that the differences in substrate specificity, and the roles of these divergent Cas1 orthologs in conferring that specificity, represent a reasonably significant advance, though this is a somewhat close call.

Minor comments:

It could be useful for the authors to tell the reader the CRISPR-Cas subtypes from which these particular Cas1/Cas2 orthologs were derived.

Reviewer \#2:

Genetic studies have shown that Cas1 is critical for novel spacer integration at CRISPR loci. Recent work with recombinant *E. coli* Cas1 by the Doudna group (Nunez et al., Nature Structural Biology, 2014, 21:528-534 and Nunez et al., Nature, 2015, 519:193-198) provided strong evidence that Cas1 functions as the integrase and that its dual transeserification activity displays sequence specificity and is strongly dependent upon association with the Cas2 protein. Furthermore, Nunez et al. demonstrated that 33 bp double-stranded DNA fragments can be integrated into CRISPR repeats by the Cas1 and Cas2 proteins and both the forward (integration) and reverse (disintegration) reactions were observed and characterized. Here, Rollie et al. report that Cas1 alone (from *E. coli* or *S. solfataricus* sources) can catalyze a single transesterification reaction on 5\' flap DNA substrates that possibly (but not definitively) mimics a disintegration reaction. The main claim in this paper is that Cas1 shows a clear sequence preference for nucleotides at the leader-repeat boundary but this is not true for both sites of integration.

The current study suffers in that it does not significantly expand our mechanistic understanding of Cas1 function or spacer acquisition beyond that reported by others ([@bib24]; Babu et al., Mol. Micro., 2011, 79:484-502). Indeed, much of the analysis reaches the conclusion that Cas1 can carry out transesterification reactions on certain branched DNA substrates--the novelty of this observation is undermined, since a transesterification mechanism was already clearly demonstrated by the recent work by Doudna and colleagues ([@bib24]). Another weakness of the paper is that it examines only the putative reverse (disintegration) reaction and the validity of the conclusion that the reaction being studied is reflective of the integration event must await reconstitution of the forward (integration) reaction. Moreover, the claim of clear sequence specificity that coincides with the in vivo integration site is not clear from the data shown. The order of sequential transesterifications resulting in spacer acquisition differs between this work and those of [@bib24]. Indeed, by systematically varying the nucleotides flanking each transesterification site, it was concluded that there is no obvious sequence specificity for site 2 ([Figure 6](#fig6){ref-type="fig"}).

Curiously, site 2 described in the paper is equivalent to the site 1 of [@bib24], which was the main site used where sequence-specificity was observed and which accounts for the in vivo observation that newly acquired spacers have a 5\' G as the first nt. flanking the leader-repeat junction that is derived from the upstream PAM. In general, the data in the paper is of high quality and the observed nucleotide specificity at +1 position of site 1 seems solid. However, it is unclear if the reaction under investigation provides a strong model for learning how the spacer acquisition reaction occurs in vivo.

Minor comments:

A relevant reference showing that nucleotides at the leader-repeat boundary are critical for new spacer acquisition was omitted and should be cited at the appropriate locations within the Introduction and Discussion. The reference is: Wei et al., Nucleic Acids Res., 2015, 43:1749-58.

Reviewer \#3:

Rollie and co-workers have characterized the sequence specificity of Cas1 from *E. coli* and *S. solfataricus*, which has been shown to be involved in the integration of spacers in the CRISPR memory locus. The authors show that these enzymes display efficient transesterification reactions, which may be considered the reversal of the integration of spacers. The manuscript is interesting, important, well written, and biochemically thorough, but would benefit from some improvements described below.

One key experiment seems to be missing. It remains unclear whether EcoCas1 prefers the disintegration reactions at site 1 or site 2. Although the authors state that the disintegration reaction occurs at site 2 as well, the design of the substrates for the disintegration reaction seems to be based on site 1, which is the leader-repeat boundary. Because a Cas1-Cas2 complex has recently been shown to start integrating spacers from site 2 ([@bib24]), it would be good to directly compare the kinetics of both disintegration reactions using the exact substrates that are now thought to be representing site 1 (leader - repeat), and other substrates representing site 2 (repeat - spacer 1), for both EcoCas1 and EcoCas1-Cas2. Has this been done? This will help understand the order of events leading to spacer integration, and take this paper to a next level.

Minor comments:

1\) The model in the left panel of [Figure 9](#fig9){ref-type="fig"} could be expanded to include more details (e.g. numbering of positions) and more steps, even if they are hypothetical. This will help understand how full spacer integration is achieved and would increase the readability of the paper.

2\) It would be good to make the figures as intuitive as possible. This includes changing lane numbering and legend description (e.g. in [Figure 2](#fig2){ref-type="fig"}) into lane text labeling in the figure.

3\) Can the markers used to indicate nucleobases C, T and A in [Figure 5B,D and 7C](#fig5 fig7){ref-type="fig"} be changed to something that is better visible (solid circle, square etc)?

10.7554/eLife.08716.021

Author response

Reviewer \#1:

*\[...\] A critical question is the degree to which the requirements for disintegration reflect those of the presumptive integration. As an example, the initial protospacer attack (forward) reaction described by Nunez et al. requires a double-stranded protospacer, whereas the disintegration liberates single-stranded (as well as double-stranded) flaps; similarly, the inclusion of Cas2 is far more important for integration than for disintegration. Overall, the history of integrase/transposase research suggests that the reverse reaction* can *be a useful and convenient proxy for the forward reaction, but this nonetheless calls for some caution in interpretation*.

*One other potential concern is that the authors used enzyme concentrations that were rather high -- 2 micromolar, according to the Materials and methods section. This is more than twenty-five-fold higher than those used by Nunez et al. Is there a reason for this? The higher concentrations could drive enzyme/substrate interactions that might not occur at concentrations that are probably closer to physiological, and could therefore obviously bear on questions of specificity. This concern is particularly meaningful in light of* [*Figure 3*B](#fig3){ref-type="fig"}*, which shows good activity in the low- to mid-nanomolar range. In fact, in light of the SsoCas1 data in* [*Figure 3*B](#fig3){ref-type="fig"}, *2-micromolar reactions should not work at all for that protein. Can the authors explain this discrepancy?*

Nuclease activity is typically measured under single turnover conditions with high enzyme excess. We show that disintegration activity can be observed over a wide range of Cas1 concentrations ([Figure 3C](#fig3){ref-type="fig"}) and have chosen concentrations that give a robust activity and therefore signal. The apparent discrepancy for the 2 µM SsoCas1 reactions is explained by the fact that the inhibition observed at high concentrations for SsoCas1 is dependent on the ratio of substrate DNA to protein. The reactions with 2 µM SsoCas1 used 200 nM substrate, whereas in [Figure 3B](#fig3){ref-type="fig"} substrate concentration is 50 nM. This has now been explained in the Methods.

Perhaps the most meaningful question is about the degree to which the results described in this manuscript move the field forward, relative to expectations for this journal. My initial reaction is that the differences in substrate specificity, and the roles of these divergent Cas1 orthologs in conferring that specificity, represent a reasonably significant advance, though this is a somewhat close call.

*Minor comments*:

*It could be useful for the authors to tell the reader the CRISPR-Cas subtypes from which these particular Cas1/Cas2 orthologs were derived*.

This has now been added to the beginning of the Results.

Reviewer \#2 (Minor comments):

*A relevant reference showing that nucleotides at the leader-repeat boundary are critical for new spacer acquisition was omitted and should be cited at the appropriate locations within the Introduction and Discussion. The reference is: Wei et al*.*, Nucleic Acids Res., 2015, 43:1749-58.*

This reference was already cited at the appropriate place in the Discussion.

Reviewer \#3:

*\[...\] One key experiment seems to be missing. It remains unclear whether EcoCas1 prefers the disintegration reactions at site 1 or site 2. Although the authors state that the disintegration reaction occurs at site 2 as well, the design of the substrates for the disintegration reaction seems to be based on site 1, which is the leader-repeat boundary. Because a Cas1-Cas2 complex has recently been shown to start integrating spacers from site 2 (*[@bib24]*), it would be good to directly compare the kinetics of both disintegration reactions using the exact substrates that are now thought to be representing site 1 (leader - repeat), and other substrates representing site 2 (repeat - spacer 1), for both EcoCas1 and EcoCas1-Cas2. Has this been done? This will help understand the order of events leading to spacer integration, and take this paper to a next level*.

This is an excellent suggestion. We have constructed DNA substrates that correspond to the site 1 and site 2 integration products for the addition of spacer 3 into the CRISPR array (new [Figure 9](#fig9){ref-type="fig"}). The disintegration activity of EcoCas1 with these substrates has been quantified in triplicate and plotted. Both substrates support disintegration, with the activity at site 1 significantly higher than for site 2. This reinforces our conclusion that disintegration can be viewed as a reversal of the half--integration reaction and that specificity of EcoCas1 for site 1 appears higher than for site 2.

*Minor comments*:

*1) The model in the left panel of* [*Figure 9*](#fig9){ref-type="fig"} *could be expanded to include more details (e.g. numbering of positions) and more steps, even if they are hypothetical. This will help understand how full spacer integration is achieved and would increase the readability of the paper*.

We agree. We have added the second integration step to this model (now [Figure 10](#fig10){ref-type="fig"}) and expanded the legend to explain this in more detail. We agree this improves the clarity.

*2) It would be good to make the figures as intuitive as possible. This includes changing lane numbering and legend description (e.g. in* [*Figure 2*](#fig2){ref-type="fig"}*) into lane text labeling in the figure*.

We have labelled each lane in [Figure 2](#fig2){ref-type="fig"} to aid the reader as suggested.

*3) Can the markers used to indicate nucleobases C*, *T and A in* [*Figure 5B,D and 7C*](#fig5 fig7){ref-type="fig"} *be changed to something that is better visible (solid circle, square etc)?*

These have now been redesigned to aid visibility.

[^1]: The sequence of the central portion of the junction (positions −2, −1, 1 and the incoming nucleotide (IC)) for each substrate is shown. The oligonucleotides used to assemble the complete substrate are indicated.
